AAM
TECH icon

Advisors Asset Management’s Bio-Techne TECH Stock Holding History

Advisors Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-772
Closed -$54.3K – 1483
2024
Q1 		$54.3K Sell
772
-86
-10% -$6.15K ﹤0.01% 1278
2023
Q4 		$66.2K Sell
858
-9,707
-92% -$639K ﹤0.01% 1247
2023
Q3 		$719K Sell
10,565
-335
-3% -$26.5K 0.02% 803
2023
Q2 		$890K Sell
10,900
-8,964
-45% -$721K 0.02% 782
2023
Q1 		$1.47M Sell
19,864
-598
-3% -$46.1K 0.03% 611
2022
Q4 		$1.7M Sell
20,462
-13,210
-39% -$1.05M 0.03% 556
2022
Q3 		$2.39M Sell
33,672
-1,108
-3% -$95.7K 0.05% 448
2022
Q2 		$3.01M Sell
34,780
-10,152
-23% -$951K 0.05% 371
2022
Q1 		$4.86M Buy
44,932
+6,024
+15% +$622K 0.07% 283
2021
Q4 		$5.03M Buy
38,908
+5,336
+16% +$654K 0.07% 285
2021
Q3 		$4.07M Buy
33,572
+4,808
+17% +$585K 0.06% 332
2021
Q2 		$3.24M Sell
28,764
-476
-2% -$50.1K 0.05% 423
2021
Q1 		$2.79M Buy
29,240
+7,424
+34% +$677K 0.04% 457
2020
Q4 		$1.73M Buy
21,816
+6,476
+42% +$469K 0.03% 613
2020
Q3 		$950K Sell
15,340
-18,244
-54% -$1.19M 0.02% 722
2020
Q2 		$2.22M Buy
33,584
+2,112
+7% +$126K 0.04% 421
2020
Q1 		$1.49M Sell
31,472
-1,152
-4% -$57.6K 0.03% 502
2019
Q4 		$1.79M Sell
32,624
-1,120
-3% -$58.8K 0.03% 564
2019
Q3 		$1.65M Sell
33,744
-17,512
-34% -$878K 0.03% 589
2019
Q2 		$2.67M Buy
51,256
+5,956
+13% +$300K 0.05% 449
2019
Q1 		$2.25M Sell
45,300
-568
-1% -$25.6K 0.04% 495
2018
Q4 		$1.66M Buy
45,868
+880
+2% +$36.8K 0.03% 591
2018
Q3 		$2.3M Buy
44,988
+14,928
+50% +$661K 0.04% 548
2018
Q2 		$1.11M Buy
30,060
+29,988
+41,650% +$1.15M 0.02% 804
2018
Q1 		$3K Buy
+72
New +$2.54K ﹤0.01% 1497
2017
Q1 		– Sell
-3,600
Closed -$93K – 1737
2016
Q4 		$93K Sell
3,600
-4,796
-57% -$126K ﹤0.01% 1534
2016
Q3 		$230K Sell
8,396
-676
-7% -$18.6K ﹤0.01% 1322
2016
Q2 		$256K Sell
9,072
-60
-0.7% -$1.54K ﹤0.01% 1290
2016
Q1 		$216K Sell
9,132
-72
-0.8% -$1.59K ﹤0.01% 1299
2015
Q4 		$207K Sell
9,204
-4,808
-34% -$110K ﹤0.01% 1387
2015
Q3 		$324K Buy
14,012
+220
+2% +$5.52K 0.01% 1235
2015
Q2 		$340K Buy
13,792
+9,392
+213% +$235K ﹤0.01% 1241
2015
Q1 		$110K Hold
4,400
– – ﹤0.01% 1493
2014
Q4 		$102K Sell
4,400
-14,748
-77% -$338K ﹤0.01% 1491
2014
Q3 		$448K Sell
19,148
-880
-4% -$20.6K 0.01% 1057
2014
Q2 		$464K Buy
20,028
+4,584
+30% +$101K 0.01% 1066
2014
Q1 		$330K Buy
15,444
+10,264
+198% +$231K 0.01% 1125
2013
Q4 		$123K Buy
5,180
+780
+18% +$16.9K ﹤0.01% 1343
2013
Q3 		$88K Hold
4,400
– – ﹤0.01% 1393
2013
Q2 		$76K Buy
+4,400
New +$73K ﹤0.01% 1391

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Advisors Asset Management's TECH Position: Q2 2024 in Review

Advisors Asset Management sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 772 shares — an estimated $54.3K sold.

Advisors Asset Management first reported a position in TECH in Q2 2013 and held it in 40 quarters. The position peaked at $5.03M in Q4 2021. 572 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

  • Advisors Asset Management reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
  • Advisors Asset Management sold 772 Bio-Techne shares in Q2 2024, an estimated $54.3K.
  • Advisors Asset Management first reported a position in Bio-Techne in Q2 2013 and held it in 40 quarters.
  • Advisors Asset Management's Bio-Techne position peaked at $5.03M in Q4 2021.
  • 572 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Advisors Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.